TY - BOOK ID - 7764432 TI - Antithrombotic drug therapy in cardiovascular disease AU - Askari, Arman T. AU - Lincoff, A. Michael. PY - 2010 SN - 1607613468 1603272348 9786612828171 1603272356 1627037977 1282828177 PB - Dordrecht ; New York : Humana Press, DB - UniCat KW - Cardiovascular system -- Diseases -- Chemotherapy. KW - Fibrinolytic agents. KW - Thrombolytic therapy KW - Cardiovascular system KW - Fibrinolytic agents KW - Cardiovascular Diseases KW - Fibrinolytic Agents KW - Thrombolytic Therapy KW - Hematologic Agents KW - Fibrin Modulating Agents KW - Drug Therapy KW - Diseases KW - Cardiovascular Agents KW - Therapeutics KW - Therapeutic Uses KW - Molecular Mechanisms of Pharmacological Action KW - Pharmacologic Actions KW - Analytical, Diagnostic and Therapeutic Techniques and Equipment KW - Chemical Actions and Uses KW - Chemicals and Drugs KW - Pharmacy, Therapeutics, & Pharmacology KW - Health & Biological Sciences KW - Medicine KW - Chemotherapy KW - Chemotherapy. KW - Circulatory system KW - Vascular system KW - Antithrombotic agents KW - Antithrombotics KW - Fibrinolytic enzymes KW - Fibrinolytics KW - Thrombolytic agents KW - Thrombolytics KW - Medicine. KW - Interventional radiology. KW - Internal medicine. KW - Cardiology. KW - Vascular surgery. KW - Medicine & Public Health. KW - Internal Medicine. KW - Interventional Radiology. KW - Vascular Surgery. KW - Vascular surgery KW - Heart KW - Internal medicine KW - Medicine, Internal KW - Radiology, Interventional KW - Medical radiology KW - Clinical sciences KW - Medical profession KW - Human biology KW - Life sciences KW - Medical sciences KW - Pathology KW - Physicians KW - Blood KW - Enzymes KW - Hematologic agents KW - Circulation KW - Interventional radiology . KW - Blood-vessels KW - Surgery. UR - https://www.unicat.be/uniCat?func=search&query=sysid:7764432 AB - Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT). ER -